About Daniel Sem
Daniel Sem is a vice president of business development and director at Estrigenix Therapeutics.
Experience
This experience comes from Daniel Sem's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Sem in the role, so the role may have started earlier or lasted longer.
Estrigenix Therapeutics, Inc. Current
Vice President of Business Development and director
Chief Technology Officer (2026 – Present)
2026 – Present · Wauwatosa, WI
Develops potential treatments for hot flashes and dementia in postmenopausal women.
TF
Talents Fund Current
Managing Partner
2025 – Present
CV
CU Ventures Current
President
2022 – Present
WF
Winnow Fund Current
Investment Committee - Observer
2021 – Present
PR
Purple Solutions - Healthcare Reform Current
Author and Editor
2020 – Present
BC
Bridge to Cures Current
CEO
2013 – Present
WC
Walsh College
Executive Director of the Center for Innovation and Entrepreneurship
2024 – 2026
WV
Walsh Ventures
President
2024 – 2026
RT
Rx Think Tank
Director of the Remedium eXchange (Rx) Think Tank
2017 – 2025
CW
Concordia University-Wisconsin
Vice Provost for Research and Innovation
2011 – 2024
LM
Launch MKE
Board Member
2020 – 2023
RT
Retham Technologies
Acting CEO and General Counsel
2017 – 2023
PO
PLoS One
Member of the Editorial Board
2011 – 2020
AL
AviMed Pharmaceuticals LLC
CEO and VP of Drug Development
2009 – 2019
BI
BioForward
Board Member
2013 – 2016
PI
PhysioGenix, Inc.
Scientific Advisor
2011 – 2015
MR
Marquette Intellectual Property Law Review
Member of the Editorial Board
2012 – 2014
MU
Marquette University
Associate Professor of Organic Chemistry (with tenure)
2002 – 2011
TT
Triad Therapeutics
Vice President for Biophysics
1998 – 2002
LC
La Jolla Pharmaceutical Company
Research Scientist
1995 – 1998
Key Colleagues at Startups
The people Daniel Sem works with at each company, as listed on that company's latest Form D.
Estrigenix Therapeutics, Inc. · Form D, Jul 27, 2026
Patricia Scheller
Executive Chair
Victoria Zellmer
Chief Executive Officer
William Donaldson
PRESIDENT & Senior VICE PRESIDENT of CHEMISTRY, director
Karyn Frick
Chief Scientific Officer